ClinicalTrials.Veeva

Menu

Motive-specific Intervention for Negative Symptoms in Schizophrenia (MoNSS)

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Unknown

Conditions

Apathy
Anhedonia
Negative Type; Schizophrenic

Treatments

Behavioral: Motive-specific intervention
Behavioral: Supportive conversations

Study type

Interventional

Funder types

Other

Identifiers

NCT04793438
2018-00916

Details and patient eligibility

About

The aim of this study is to test a therapeutic intervention to reduce negative symptomatic among schizophrenia patients. Since the intervention can take place within an inpatient stay, it is a short intervention. Three appointments are made with the patients within two weeks. With an adaptation of the Autobiographical Memory Test (AMT) participants will be asked to recall events from the past and to imagine future events. Patients are additionally asked to complete tasks between the sessions. One pre- and one post-measurement of negative symptoms, motives, level of functioning, hope for recovery and other co-variables are part of the study. A follow-up appointment four weeks later is intended to provide information on the longer-term impact.

Full description

Clinically relevant negative symptoms are present in almost 60% of all patients suffering from schizophrenia. Motivational deficits seem to be one of the main barriers in the process of "functional recovery" among those patients and have been shown to be very treatment resistant. Effects of pharmacological compounds are at best moderate. There are some psychotherapeutic intervention studies that show promise but further controlled trials are needed to clarify the specific treatment effects.

Therefore, patients shall be encouraged to remember memories that stand in an association with specific motives. Motives are conscious and unconscious affect-based needs that are activated by behavior and influence behavior toward specific incentives in specific circumstances. They influence the selection of everyday goals and have influence on the degree of the progress people are making towards these goals. The intervention is based on the assumption that a positive expectation of the future is constituted among others by positive experiences from the past and at the same time increases the motivation for future behaviour. The activation of specific, motive-associated memories from autobiographical memory and their transformation into images of the future by means of imaginative methods could be a possible way of strengthening certain motives and thus increasing motivation for certain behaviour. This is mainly because there is evidence that psychosis patients have difficulties specifically remembering memories, i.e. those that happened on only one day. In addition, there is a diminished ability to create specific images of their personal future.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Informed Consent as documented by signature
  • Male and female inpatients between 18 and 65 years of age
  • ICD-10 diagnosis of psychosis (F2)
  • Clinical relevant negative symptoms
  • Ability to judge with regard to decisions on study participation
  • Fluent in German and able to understand the instructions

Exclusion criteria

  • Florid positive psychotic symptoms (measured with PANSS; that is any positive-subscale item score higher than five)
  • Post-schizophrenic depression (ICD: F20.4)
  • Organic schizophrenia-like disorder (ICD: F0.6)
  • Known or suspected non-compliance, drug or alcohol abuse during treatment
  • Cognitive impairments: strongly below average values in cognitive tests
  • Complete stop or restart of taking antipsychotic medication during the study (dose adjustments are not a reason for exclusion)
  • Previous enrolment in the current study
  • Enrolment of the investigator, his/her family members, employees and other dependent persons.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Intervention group
Experimental group
Description:
Motive-specific intervention; three appointments within two weeks, 30-45 minutes per session.
Treatment:
Behavioral: Motive-specific intervention
Control group
Active Comparator group
Description:
Supportive conversations; three appointments within two weeks; 30-45 minutes per session.
Treatment:
Behavioral: Supportive conversations

Trial contacts and locations

1

Loading...

Central trial contact

Kleim Birgit, Prof. Dr.; Rahel Horisberger, M.Sc.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems